Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.

Sadate-Ngatchou P, Carter JJ, Hawes SE, Feng Q, Lasof T, Stern JE, Fu TC, Galloway DA, Koutsky LA, Winer RL.

Sex Transm Dis. 2016 Mar;43(3):192-8. doi: 10.1097/OLQ.0000000000000409.

2.

Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.

Winer RL, Hughes JP, Feng Q, Xi LF, Lee SK, O'Reilly SF, Kiviat NB, Koutsky LA.

Sex Transm Dis. 2012 Nov;39(11):848-56. doi: 10.1097/OLQ.0b013e3182641f1c. Erratum in: Sex Transm Dis. 2013 Nov;40(11):898.

3.

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.

Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D; HPV-039 study group.

Int J Cancer. 2014 Dec 1;135(11):2604-11. doi: 10.1002/ijc.28896. Epub 2014 May 20.

4.

Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.

Althoff KN, Paul P, Burke AE, Viscidi R, Sangaramoorthy M, Gravitt PE.

J Womens Health (Larchmt). 2009 Sep;18(9):1341-6. doi: 10.1089/jwh.2008.1223.

5.

Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.

Namujju PB, Waterboer T, Banura C, Muwonge R, Mbidde EK, Byaruhanga R, Muwanga M, Surcel HM, Pawlita M, Lehtinen M.

J Gen Virol. 2011 Dec;92(Pt 12):2776-83. doi: 10.1099/vir.0.035923-0. Epub 2011 Aug 10.

PMID:
21832008
6.

Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters.

Barrere A, Stern JE, Feng Q, Hughes JP, Winer RL.

Sex Transm Dis. 2015 Sep;42(9):492-7. doi: 10.1097/OLQ.0000000000000331.

7.

Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.

Tay SK, Oon LL.

Int J STD AIDS. 2014 Dec;25(14):1013-21. doi: 10.1177/0956462414528315. Epub 2014 Mar 19.

PMID:
24648316
8.

Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Fu TC, Carter JJ, Hughes JP, Feng Q, Hawes SE, Schwartz SM, Xi LF, Lasof T, Stern JE, Galloway DA, Koutsky LA, Winer RL.

Int J Cancer. 2016 Nov 15;139(10):2201-12. doi: 10.1002/ijc.30283. Epub 2016 Aug 4.

9.

Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.

Mollers M, Scherpenisse M, van der Klis FR, King AJ, van Rossum TG, van Logchem EM, Feltkamp MC, Meijer CJ, Snijders PJ, Boot HJ, de Melker HE.

Cancer Epidemiol. 2012 Dec;36(6):519-24. doi: 10.1016/j.canep.2012.07.006. Epub 2012 Aug 17.

PMID:
22906483
10.

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.

Rahman S, Pierce Campbell CM, Rollison DE, Wang W, Waterboer T, Michel A, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Giuliano AR.

PLoS One. 2016 Nov 30;11(11):e0167173. doi: 10.1371/journal.pone.0167173. eCollection 2016.

11.

Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria.

Okunade KS, Nwogu CM, Oluwole AA, Anorlu RI.

Pan Afr Med J. 2017 Nov 14;28:227. doi: 10.11604/pamj.2017.28.227.13979. eCollection 2017.

12.

Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.

Sangwa-Lugoma G, Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL.

Sex Transm Dis. 2011 Apr;38(4):308-15. doi: 10.1097/OLQ.0b013e3181fc6ec0.

PMID:
21150817
13.

Oral HPV infection and sexuality: a cross-sectional study in women.

Ragin C, Edwards R, Larkins-Pettigrew M, Taioli E, Eckstein S, Thurman N, Bloome J, Markovic N.

Int J Mol Sci. 2011;12(6):3928-40. doi: 10.3390/ijms12063928. Epub 2011 Jun 10.

14.

Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.

O'Keefe EJ, Gardner A, Currie MJ, Garland S, Tabrizi S, Bowden FJ.

Sex Health. 2006 May;3(2):91-4.

PMID:
16800394
15.

Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.

Castle PE, Shields T, Kirnbauer R, Manos MM, Burk RD, Glass AG, Scott DR, Sherman ME, Schiffman M.

Sex Transm Dis. 2002 Mar;29(3):182-7.

PMID:
11875380
16.

Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.

Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M; Costa Rica HPV Vaccine Trial (CVT) Group.

Sex Transm Dis. 2010 Nov;37(11):706-14. doi: 10.1097/OLQ.0b013e3181e1a2c5.

PMID:
20661178
17.

Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.

Kreimer AR, Alberg AJ, Viscidi R, Gillison ML.

Sex Transm Dis. 2004 Apr;31(4):247-56.

PMID:
15028941
18.

Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico.

Parada R, Morales R, Giuliano AR, Cruz A, Castellsagué X, Lazcano-Ponce E.

BMC Infect Dis. 2010 Jul 28;10:223. doi: 10.1186/1471-2334-10-223. Erratum in: BMC Infect Dis. 2011;11:25.

19.

Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women.

Fu TC, Hughes JP, Feng Q, Hulbert A, Hawes SE, Xi LF, Schwartz SM, Stern JE, Koutsky LA, Winer RL.

Sex Transm Dis. 2015 Dec;42(12):677-85. doi: 10.1097/OLQ.0000000000000362.

20.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812

Supplemental Content

Support Center